Rotenone Model of Parkinson Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4Deltapsi of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in O*2- or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of O*2- generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts O*2- generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blockade of rotenone to the binding site of ubiquinone leads to reduced electron flow to complex III and reverse electron flow through complex I into the mitochondrial matrix leading to increased ROS generation in this compartment, namely matrix mtROS [269,416,419,420,421].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [420]
In the citing paper
“ROS can damage TCA-cycle enzymes, especially aconitase and α-ketoglutarate dehydrogenase (62, 168, 249, 250, 277).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
In the citing paper
“Succinate dehydrogenase (complex II) is very resistant to oxidation by H2O2 or tert-butyl hydroperoxide (tert-BuOOH) (250), but α-ketoglutarate dehydrogenase activity is markedly decreased (168, 250) because of its susceptibility for modification by peroxides of its thiol groups (167, 249).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
Citations
Cites
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationSuperoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationNeurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Self-citationCadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Activation of molecular oxygen by flavins and flavoproteins.
Massey, V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31664-2 · Cited by 816
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Self-citation
Research works printed but not linked: 2
- Cluskey, 2001, Mol. Pathol., 54, 386
- Sherer, 2003, Ann. Neurol., 341, 87
Cited by
Items 101–200 of 311
Autophagy protects the rotenone-induced cell death in α-synuclein overexpressing SH-SY5Y cells
Dadakhujaev, S., Noh, H. S., Jung, E. J., Cha, J. Y., Baek, S. M., Ha, J. H., & Kim, D. R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.053 · Cited by 68
Panov, A., Schonfeld, P., Dikalov, S., Hemendinger, R., Bonkovsky, H. L., & Brooks, B. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900985200 · Cited by 62
Self-citationRačay, P., Tatarková, Z., Chomová, M., Hatok, J., Kaplán, P., & Dobrota, D. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9934-7 · Cited by 66
“production in different in vitro [49, 50 ] and in vivo systems [44, 51, 52].”
BackgroundEffects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
Ulusoy, K. G., Çelik, T., Kayır, H., Gürsoy, M., Işık, A. T., & Uzbay, T. I. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.05.001 · Cited by 65
ROS production in brown adipose tissue mitochondria: The question of UCP1-dependence
Shabalina, I. G., Vrbacký, M., Pecinová, A., Kalinovich, A., Drahota, Z., Houštěk, J., Mráček, T., Cannon, B., & Nedergaard, J. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.04.005 · Cited by 65
“The cyclic hydroxyl-amine PPH (Noxygen Science Transfer & Diagnostics GmbH) was used for measurements of superoxide production by mitochondria [29].”
MethodThe human GLUD2 glutamate dehydrogenase and its regulation in health and disease
Plaitakis, A., Latsoudis, H., & Spanaki, C. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.015 · Cited by 62
“Previous studies, however, utilizing the rotenone toxicity model for PD, have shown that glutamate oxidizing brain mitochondria generate increased amounts of ROS (Panov et al., 2005).”
Wu, F., Wang, Z., Gu, J., Ge, J., Liang, Z., & Qin, Z. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.05.006 · Cited by 61
Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration
Jauhari, A., Singh, T., Mishra, S., Shankar, J., & Yadav, S. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa066 · Cited by 60
Pisani, A., Martella, G., Tscherter, A., Costa, C., Mercuri, N. B., Bernardi, G., Shen, J., & Calabresi, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.001 · Cited by 50
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Tozzi, A., Tantucci, M., Marchi, S., Mazzocchetti, P., Morari, M., Pinton, P., Mancini, A., & Calabresi, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0221-2 · Cited by 54
Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset
Plaitakis, A., Latsoudis, H., Kanavouras, K., Ritz, B. R., Bronstein, J. M., Skoula, I., Mastorodemos, V. C., Papapetropoulos, S., Borompokas, N., Zaganas, I. V., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.179 · Cited by 59
Effects of chronic low dose rotenone treatment on human microglial cells
Shaikh, S. B., & Nicholson, L. F. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-55 · Cited by 51
Khan, M. S., Nasiripour, S., & Bopassa, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136416 · Cited by 57
trans-Resveratrol as A Neuroprotectant
Robb, E. L., & Stuart, J. A. (2010) · Molecules · doi:10.3390/molecules15031196 · Cited by 56
Strawberry consumption alleviates doxorubicin-induced toxicity by suppressing oxidative stress
Giampieri, F., Álvarez-Suárez, J. M., Gasparrini, M., Forbes-Hernández, T. Y., Afrin, S., Bompadre, S., Rubini, C., Zizzi, A., Astolfi, P., Santos‐Buelga, C., et al. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.003 · Cited by 56
Neural Repair Strategies for Parkinson's Disease: Insights from Primate Models
Soderstrom, K. E., O’Malley, J. A., Steece‐Collier, K., & Kordower, J. H. (2006) · Cell Transplantation · doi:10.3727/000000006783982025 · Cited by 56
Han, G., Casson, R. J., Chidlow, G., & Wood, J. P. M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14371 · Cited by 55
Simulated microgravity‐induced mitochondrial dysfunction in rat cerebral arteries
Zhang, R., Ran, H., Cai, L., Zhu, L., Sun, J., Peng, L., Liu, X., Zhang, L. Y., Fang, Z., Fan, Y., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-245654 · Cited by 54
Sapkota, K., Kim, S., Park, S., & Kim, S.-J. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9609-6 · Cited by 53
“Mitochondrial electron transport is a major source of free radical production in cells and impairment of complex I activity by rotenone leads to excess ROS formation, which is involved in formation of the mitochondrial permeability transition results in cell death (Jenner 2003; Panov et al. 2005; Radad et al. 2006; Te…”
BackgroundPérez‐Ortiz, J. M., Tranque, P., Burgos, M., Vaquero, C. F., & Llopis, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032458 · Cited by 53
Walia, V., Chaudhary, S. K., & Kumar Sethiya, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104939 · Cited by 51
Banerjee, K., Munshi, S., Sen, O., Pramanik, V., Mukherjee, T. R., & Chakrabarti, S. (2014) · Parkinson s Disease · doi:10.1155/2014/878935 · Cited by 51
An effective novel delivery strategy of rasagiline for Parkinson's disease
Fernández, M., Negro, S., Slowing, K., Fernández-Carballido, A. M., & Barcia, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.029 · Cited by 51
“Moreover, Panov et al. (2005) showed that rotenone intoxication for 6 days resulted in multiple mitochondrial dysfunctions which included increased reactive oxygen species (ROS) production and inhibition of NAD-dependent substrate oxidation.”
BackgroundThe neurotoxicity of pesticides: Implications for Parkinson's disease
Amaral, L., Martins, M., Côrte‐Real, M., Outeiro, T. F., Chaves, S. R., & Rego, A. (2025) · Chemosphere · doi:10.1016/j.chemosphere.2025.144348 · Cited by 50
“Chronic low-dose exposure of rotenone has been shown to induce significant nigrostriatal degeneration in animal models (Betarbet et al., 2000; Panov et al., 2005; Sherer et al., 2003a, 2003b, 2003c), partly through disruption of key proteins involved in DA homeostasis, including TH, DAT, and VMAT2…”
Panov, A. V., Kubalik, N., Zinchenko, N., Ridings, D. M., Radoff, D. A., Hemendinger, R., Brooks, B. R., & Bonkovsky, H. L. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00528.2010 · Cited by 47
Self-citationKim, Y. J., Ko, H. H., Han, E. S., & Lee, C. S. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.12.006 · Cited by 50
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 49
“As a matter of fact, Panov et al. (2005) provided evidence that inhibition of respiration by superoxide, at the levels of complex I and complex II, may result from damage to 4Fe-4S clusters.”
Kavitha, M., Manivasagam, T., Essa, M. M., Tamilselvam, K., Selvakumar, G. P., Karthikeyan, S., Thenmozhi, J. A., & Subash, S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1249-7 · Cited by 48
Differential production of superoxide by neuronal mitochondria
Hoegger, M. J., Lieven, C. J., & Levin, L. A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-4 · Cited by 48
Bioenergetic adaptation in response to autophagy regulators during rotenone exposure
Giordano, S. S., Dodson, M. B., Ravi, S., Redmann, M., Ouyang, X., Usmar, V. M. D., & Zhang, J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12844 · Cited by 48
Puranam, K. L., Wu, G., Strittmatter, W. J., & Burke, J. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.007 · Cited by 48
Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 47
Piskernik, C., Haindl, S., Behling, T., Zanoni, G., Kehrer, I., Redl, H. R., & Kozlov, A. V. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.007 · Cited by 47
Mulcahy, P. J., Walsh, S., Paucard, A., Rea, K., & Dowd, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.038 · Cited by 46
de Oliveira, D. M., Barreto, G. E., Galeano, P., Romero, J. I., Holubiec, M. I., Badorrey, M. S., Capani, F., & Alvarez, L. D. G. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110389837 · Cited by 46
Cellular mechanisms of complex I-associated pathology
Abramov, A. Y., & Angelova, P. R. (2019) · Biochemical Society Transactions · doi:10.1042/bst20191042 · Cited by 46
de Pedro, N., Cautain, B., Melguizo, Á., Vicente, F., Genilloud, O., Peláez, F., & Tormo, J. R. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9489-1 · Cited by 47
“…the mitochondrial Complex I by rotenone induces cell death by activating the apoptotic mitochondrial pathway (Wolvetang et al. 1994; Li et al. 2003; Panov et al. 2005; Radad et al. 2006): the inhibition of the mitochondrial electron transport chain by rotenone induces an increase of reactive…”
BackgroundInfluentialRossato, F. A., Zecchin, K. G., Guardia, P. G. L., Ortega, R. M., Alberici, L. C., Costa, R. A. P. E., Catharino, R. R., Graner, E., Castilho, R. F., & Vercesi, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101060 · Cited by 45
Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders
Kay, L., Pienaar, I. S., Cooray, R., Black, G. W., & Soundararajan, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0927-x · Cited by 45
Neurotoxins and neurotoxicity mechanisms. an overview
Segura‐Aguilar, J., & Kostrzewa, R. M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033362 · Cited by 44
Shashidharan, P., & Plaitakis, A. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1227-5 · Cited by 43
Mechanisms of retinal ganglion specific-cell death in Leber hereditary optic neuropathy.
Levin, L. A. (2007) · PubMed Central · Cited by 43
Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease
Goiran, T., Eldeeb, M. A., Zorca, C. E., & Fon, E. A. (2022) · Cells · doi:10.3390/cells11132097 · Cited by 43
“Once internalized into neurons, MPP+ is rapidly concentrated in mitochondria [98–100], blocking electron transfer at complex I [101].”
BackgroundPyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson’s disease
Qin, J., Wu, M., Yu, S., Gao, X., Zhang, J., Dong, X., Ji, J., Zhang, Y., Zhou, L., Zhang, Q., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.08.011 · Cited by 43
Sajini, D. V., Krishnamurthy, P. T., Chakkittukandiyil, A., & Naik, M. R. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04099-8 · Cited by 41
Hwang, R., Wiemerslage, L., LaBreck, C. J., Khan, M. H., Kannan, K., Wang, X., Zhu, X., Lee, D., & Fridell, Y.-W. C. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.032 · Cited by 40
Costa, R. A. P. E., Fernandes, M. P., de Souza-Pinto, N. C., & Vercesi, A. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.001 · Cited by 40
Beyond mitochondria: Alternative energy-producing pathways from all strata of life
Auger, C., Vinaik, R., Appanna, V. D., & Jeschke, M. G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154733 · Cited by 39
Patel, P. A., Pol, A. S., Kalaria, D. R., Date, A. A., Kalia, Y. N., & Patravale, V. B. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.026 · Cited by 38
A FRET-based method to study protein thiol oxidation in histological preparations
Mastroberardino, P. G., Orr, A. L., Hu, X., Na, H. M., & Greenamyre, J. T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.018 · Cited by 37
“Chronic treatment of rats with rotenone to model Parkinson’s disease induces oxidative stress and protein carbonylation [14,19–21].”
MethodSelf-citationZhang, Q., Zhang, J., Jiang, C., Qin, J., Ke, K., & Ding, F. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.022 · Cited by 36
Guo, S., Cui, X.-L., & Rausch, W. (2016) · Europe PMC (PubMed Central) · Cited by 36
Lakkappa, N., Krishnamurthy, P. T., Pandareesh, M. D., Hammock, B. D., & Hwang, S. H. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.11.010 · Cited by 36
“ROT is a potent mitochondrial complex-I inhibitor reported to induce neurotoxicity specific to dopaminergic neurons through mitochondrial dysfunctioning, and ROS production (Alam and Schmidt, 2002; Panov et al., 2005).”
Jesse, S., Steinacker, P., Lehnert, S., Gillardon, F., Hengerer, B., & Otto, M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00064.x · Cited by 33
Mariappan, N., Elks, C. M., Haque, M., & Francis, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046568 · Cited by 33
“1-Hydroxy-3-methoxycarbonyl2,2,5,5-tetramethyl-pyrrolidine (CMH) was used to measure tissue ROS and superoxide O2 , 1-hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine (CPH) was used for measurement of tissue peroxynitrite (OONO(2)); and 1-hydroxy-4-phosphono-oxy2,2,6,6-tetramethyl-piperidine (PPH) was used for mitocho…”
MethodMorota, S., Månsson, R., Hansson, M. J., Kasuya, K., Shimazu, M., Hasegawa, E., Yanagi, S., Omi, A., Uchino, H., & Elmér, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.036 · Cited by 33
Synaptic Protein Alterations in Parkinson’s Disease
Pienaar, I. S., Burn, D. J., Morris, C. M., & Dexter, D. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8226-9 · Cited by 32
Spanaki, C., Zaganas, I. V., Kounoupa, Z., & Plaitakis, A. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.020 · Cited by 32
Joseph, K. M. D., & Muralidhara, M. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.01.020 · Cited by 32
“Consequently many workers have attempted to attenuate ROT-induced oxidative stress, mitochondrial dysfunctions and neurotoxicity in animal models using various therapeutic agents (Panov et al., 2005; Shinomol et al., 2011).”
BackgroundMitochondrial Transplantation Therapy Ameliorates Muscular Dystrophy in mdx Mouse Model
Dubinin, M. V., Mikheeva, I. B., Stepanova, A. E., Igoshkina, A. D., Cherepanova, A. A., Semenova, A. A., Sharapov, V. A., Kireev, I. I., & Belosludtsev, K. N. (2024) · Biomolecules · doi:10.3390/biom14030316 · Cited by 31
“Mitochondrial Ca 2+ transport was estimated by arsenazo III absorbance (675–685 nm) using Varioskan LUX spectrofluorimeter (Thermo Fisher Scientific, Waltham, MA, USA) [21].”
MethodGopi, M., & Janardhanam, V. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.02.005 · Cited by 30
“ROT inhibits mitochondrial complex I and generates ROS (Li et al., 2003; Panov et al., 2005) and dopamine localization from vesicles to the cytosol which is involved in ROT-infused apoptosis.”
Engel, D. F., de Oliveira, J., Lieberknecht, V., Rodrigues, A. L. S., Bem, A. F. D., & Gabilan, N. H. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2433-3 · Cited by 30
Milanese, C., Tapias, V., Gabriels, S., Cerri, S., Levandis, G., Blandini, F., Tresini, M., Shiva, S., Greenamyre, J. T., Gladwin, M. T., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.6992 · Cited by 29
Self-citationPaterson, A. W. J., Curtis, J. C., & MacLeod, N. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05123.x · Cited by 29
“…shown to affect mitochondrial elongation and branching in cultured skin fibroblasts (Koopman et al. 2005), and increased cytosolic calcium levels have been shown to produce ‘swelling’ in mitochondria of both neurones (Shalbuyeva et al. 2006) and glia (Kahlert and Reiser 2002; Panov et al. 2005).”
BackgroundEstrogen Modification of Human Glutamate Dehydrogenases Is Linked to Enzyme Activation State
Borompokas, N., Papachatzaki, M.-M., Kanavouras, K., Mastorodemos, V. C., Zaganas, I. V., Spanaki, C., & Plaitakis, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146084 · Cited by 29
Polyethylene Glycol Protects Injured Neuronal Mitochondria
Chen, H., Quick, E. D., Leung, G., Hamann, K., Fu, Y., Cheng, J., & Shi, R. (2009) · Pathobiology · doi:10.1159/000209389 · Cited by 28
Al‐Quraishy, S., Dkhil, M. A., & Moneim, A. E. A. (2012) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2012.04.005 · Cited by 28
Effect of Bovine Serum Albumin on Mitochondrial Respiration in the Brain and Liver of Mice and Rats
Panov, A. V., Андреевич, В. В., Lyakhovich, V. V., Brooks, B., & Bonkovsky, H. L. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-0904-5 · Cited by 28
Self-citationPearce, L. L., Martinez-Bosch, S., Manzano, E. L., Winnica, D., Epperly, M. W., & Peterson, J. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.12.001 · Cited by 28
Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons
Wu, Y.-N., & Johnson, S. W. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.01.002 · Cited by 27
Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration
Troulinaki, K., & Bano, D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00244 · Cited by 27
Serrano‐García, N., Fernández‐Valverde, F., Luis‐García, E. R., Granados-Rojas, L., Juárez-Zepeda, T. E., Orozco-Suárez, S. A., Pedraza‐Chaverrí, J., Orozco‐Ibarra, M., & Jiménez‐Anguiano, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.015 · Cited by 26
“In other experiments, where brain mitochondrial function was measured after short-term rotenone administration, no decreased RCR was found, despite significant reductions in state 3 (Panov et al., 2005).”
Abdel‐Salam, O. M. E., Youness, E. R., Khadrawy, Y. A., Mohammed, N. A., Abdel-Rahman, R. F., Omara, E. A. A., & Sleem, A. A. (2014) · Comparative Clinical Pathology · doi:10.1007/s00580-014-1907-9 · Cited by 26
Plant Disease Management in Organic Farming System: Strategies and Challenges
Rawat, L., Bisht, T. S., & Naithani, D. C. (2020) · Springer eBooks · doi:10.1007/978-981-15-6275-4_27 · Cited by 25
Age-Related Deterioration of Mitochondrial Function in the Intestine
Schneider, A.-M., Özsoy, M., Zimmermann, F., Feichtinger, R. G., Mayr, J. A., Kofler, B., Sperl, W., Weghuber, D., & Mörwald, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4898217 · Cited by 25
“Furthermore, rats treated with rotenone, an inhibitor of complex I activity, showed increased levels of ROS production and damage to brain mitochondria [87].”
BackgroundSumbalová, Z., Kucharská, J., & Kristek, F. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9501-4 · Cited by 25
Exploring the interaction between rotenone and human serum albumin
Fan, X., Zhang, Y., Wang, J., Yang, L., Jiang, F., & Liu, Y. (2013) · The Journal of Chemical Thermodynamics · doi:10.1016/j.jct.2013.10.021 · Cited by 23
Endocytic iron trafficking and mitochondria in Parkinson’s disease
Cerri, S., Milanese, C., & Mastroberardino, P. G. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.009 · Cited by 22
Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model
Arana, A. G. H., Vitar, R. M. L., Reides, C. G., Calabró, V., Marchini, T., Lerner, S. F., Evelson, P., & Ferreira, S. M. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108815 · Cited by 21
Pienaar, I. S., Schallert, T. J., Hattingh, S. M., & Daniels, W. M. U. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0247-4 · Cited by 20
“This finding is consistent with the possibility that statins can partially limit rotenone-induced degeneration of DA-ergic and non-DA-ergic neurons in the SN ( Panov et al. 2005; Testa et al. 2005; Zhang et al. 2006).”
ResultEffect of Rotenone on the Neurodegeneration among Different Models
Subhan, I., & Siddique, Y. H. (2024) · Current Drug Targets · doi:10.2174/0113894501281496231226070459 · Cited by 19
Dikalov, S., Mayorov, V., & Panov, A. V. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00907 · Cited by 19
“The cyclic hydroxyl-amine PPH (Enzo Life Sciences, Inc., Farmingdale, NY) was used for measurements of O2 • release by mitochondria (Panov et al., 2005).”
MethodInfluentialSelf-citationKolosova, N. G., Евгеньевич, А. А., Stefanova, N. A., Moshkin, M. P., Savelov, A. A., Koptyug, I. V., Panov, A. V., & Андреевич, В. В. (2011) · Doklady Biological Sciences · doi:10.1134/s0012496611020049 · Cited by 19
Self-citationLiterature-Related Discovery (LRD)
Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19
Zaigham, S. B., & Paeng, D. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080545 · Cited by 18
“In 2000, the Greenamyre group reported that systematic rotenone could reproduce the two pathological hallmarks of PD as well as certain parkinsonian motor deficits [33].”
BackgroundInhibition by rotenone of mesencephalic neural stem-cell migration in a neurosphere assay in vitro
Ishido, M., & Suzuki, J. S. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.11.005 · Cited by 18
Choi, J., Polcher, A. A., & Joas, A. (2016) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2016.en-955 · Cited by 18
Role of phytotherapy in diabetic neuropathy and neurodegeneration: from pathogenesis to treatment
Solanki, N. D., Bhavsar, S. K., & Pandya, D. (2018) · The Journal of Phytopharmacology · doi:10.31254/phyto.2018.7209 · Cited by 17
López, S., Martá-Ariza, M., Sequeda-Castañeda, L. G., Celis, C. A., Sutachan, J. J., & Albarracín, S. L. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.025 · Cited by 17
“However, when antiradical systems are impaired, ROS can start redox reactions that oxidize some biological molecules that lead to deleterious intracellular effects.”
BackgroundInfluentialNeurotoxic risks of long-term environmental exposure to pesticides: a review
Leng, Y., Zeng, Y., Zhang, Y., Zhang, J., Xin, H., Hou, M., Ma, S., & Zhang, H. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111626 · Cited by 16
Induction of apoptosis by antimycin A in differentiated PC12 cell line
Xu, L., Xu, J., Shichang, L., & Yang, Z. R. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2890 · Cited by 16
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Ramachandra, V. H., Sivanesan, S., Koppal, A., Anandakumar, S., Howell, M. D., Sukumar, E., & Vijayaraghavan, R. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0224 · Cited by 14
Krishnan, M. (2023) · Bioinformation · doi:10.6026/97320630019729 · Cited by 14
Neonatal rotenone lesions cause onset of hyperactivity during juvenile and adulthood in the rat
Ishido, M., Suzuki, J. S., & Masuo, Y. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.008 · Cited by 14
Ismael, S., Colvin, R. A., & Lee, D. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148641 · Cited by 13
Hayworth, C. R., Rojas, J. C., & Gonzalez-Lima, F. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390802414190 · Cited by 13
“By inhibiting complex I, rotenone induces oxidative stress that may lead to the activation of apoptotic cascades (Sherer et al., 2002) and has been used in animal models of neurodegeneration, especially Parkinson’s disease (Betarbet et al., 2000; Ferrante et al., 1997; Greenamyre et al., 2001; Panov et al., 2005; Sher…”
MethodDutta, A., Roy, R., Pandey, M., Chhetry, S., Phukan, B. C., Roy, A., Bhattacharya, P., & Borah, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149493 · Cited by 12
The Roles of Calcium Ions in Parkinson’s Disease: Calcium Channel Inhibitors as a Novel Agents?
Alam, M. R., Raj, K., & Singh, S. (2022) · Journal of Molecular Pathology · doi:10.3390/jmp3040021 · Cited by 12
Márquez‐Ramírez, C. A., Olmos‐Orizaba, B. E., Garcia‐Berumen, C. I., Calderón‐Cortés, E., Montoya-Pérez, R. D. C., Saavedra‐Molina, A., Rodríguez-Orozco, A. R., & Cortés‐Rojo, C. (2021) · Life · doi:10.3390/life11111122 · Cited by 12
Wieloch, T. W., Mattiasson, G., Hansson, M. J., & Elmér, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_25 · Cited by 12
Metadata
- Authors
- Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., & Greenamyre, J. T.
- Affiliations
- Carolinas Healthcare System (US)
- Emory University (US)
- Corresponding author
- Panov, Alexander
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 51
- Pages
- 42026-42035
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1996971085
- Cited by
- 288
- References
- 54
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 8 · 2014: 19 · 2013: 24 · 2012: 15
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5419 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES012068, U54ES012068)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- rotenone, Parkinson's disease, mitochondrial complex I, complex II, reactive oxygen species, superoxide production, mitochondrial permeability transition, mitochondrial respiration, glutamate oxidation, succinate oxidation, [4Fe-4S] cluster, apoptosis, Lewis rats
- MeSH terms
- Animals, Brain, Disease Models, Animal, Male, Mitochondria, Parkinson Disease, Rats, Inbred Lew, Rotenone, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.